 |
 |
Product ID |
Structure |
Product Name |
Purity |
Price |
Delete |
AS-3675 |
 |
(S)-(+)-4-Phenyl-2-oxazolidinone |
98%
|
|
Delete |
A1-0282 |
 |
1-Boc-3-Phenylpiperidin-4-one |
>95%
|
1g/$245 |
Delete |
A1-5491 |
 |
1-N-Boc-2(S)-Methyl-5(S)-benzyl piperazine |
>96%
|
POA |
Delete |
A1-4254 |
 |
2,3-DIFLUOROBENZYLAMINE |
97
|
50g/$39525g/$255 |
Delete |
AS-3710 |
 |
2-(Trimethylsilyl)ethoxymethyl chloride |
98%
|
|
Delete |
AS-1426 |
 |
2-Amino-5-iodopyridine |
98%
|
|
Delete |
AS-3436 |
 |
2-Chlorobenzaldehyde |
98%
|
|
Delete |
AS-1160 |
 |
2-Methoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
98%
|
|
Delete |
AS-7337 |
 |
3-Aminopiperidine dihydrochloride |
98%
|
|
Delete |
JR6-L4489 |
 |
3-Pyrrolidinol, 1-[3,5-bis(trifluoromethyl)phenyl]-, (3R)- |
96%
|
|
Delete |
AS-0256 |
 |
4-AMINO-2-METHYLANISOLE |
98%
|
|
Delete |
AS-6449 |
 |
4-BROMO-3,3,4,4-TETRAFLUORO-1-BUTANOL |
98%
|
|
Delete |
AS-3243 |
 |
4-Methylbenzyl bromide |
98%
|
|
Delete |
JR6-L6897 |
 |
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)oxazole |
96%
|
$1480/1g, $4280/5g, $7180/10g |
Delete |
AS-8913 |
 |
5-Bromovanillin |
98%
|
|
Delete |
AS-3948 |
 |
5-Chlorovaleryl chloride |
98%
|
|
Delete |
JR8-N0520 |
 |
8-Methoxypsoralen |
98%
|
|
Delete |
JR6-L3526 |
 |
Benzeneethanol, a-(chloromethyl)-2,5-difluoro-4-methoxy-, (aS)- |
96%
|
|
Delete |
JR6-L2463 |
 |
Benzenemethanol, 2-methoxy-a-(trifluoromethyl)- |
96%
|
$480/1g, $780/2g, $1280/5g, $3980/25g |
Delete |
JR6-L2163 |
 |
Benzenepropanoic acid, ß-amino-4-chloro-, methyl ester, (ßR)- |
96%
|
$580/1g, $980/2g, $1980/5g |
Delete |
AS-5375 |
 |
DIETHYL 2-BROMOETHYLPHOSPHONATE |
98%
|
|
Delete |
JR8-N0578 |
 |
Epoxylathyrol |
98%
|
|
Delete |
JR6-L7816 |
 |
Oxirane, 2-(1-naphthalenyl)-, (2S)- |
96%
|
|
Delete |
JR8-N0483 |
 |
Praeruptorin E |
98%
|
$128/5mg, $280/20mg |
Delete |
AS-8421 |
 |
tert-butyl 2-chloro-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate |
98%
|
|
Delete |
AS-6491 |
 |
Trimethylsilyl 2-(fluorosulfonyl)difluoroacetate |
98%
|
|
Delete |
Continue browsing products
Quote/Order
Inquiry
|
|
|
 |
 |
 |